Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA's Oncologic Drugs Advisory Committee

Executive Summary

FDA's Oncologic Drugs Advisory Committee: Will meet Dec. 14 to discuss Bryant Corp.'s Luzenac sterile aerosol talc (NDA 20-587) for treatment of malignant pleural effusion and NeoRx' monoclonal antibody OncoTrac (PLA 94-0308) for small-cell lung cancer. Boehringer Ingelheim retains exclusive marketing rights to OncoTrac outside North America, and NeoRx is in a marketing alliance with DuPont Merck for the North American rights to the product. The advisory committee also will discuss FDA oncology initiatives. The meeting will take place at the Bethesda Holiday Inn, Bethesda, Md., beginning at 8 a.m...
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027261

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel